Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.

Androgen replacement therapy: present and future.

Gooren LJ, Bunck MC.

Drugs. 2004;64(17):1861-91. Review.

PMID:
15329035
2.

Advances in testosterone replacement therapy.

Gooren LJ.

Front Horm Res. 2009;37:32-51. doi: 10.1159/000175842. Review.

PMID:
19011287
3.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA.

Clin Endocrinol (Oxf). 1997 Dec;47(6):727-37.

PMID:
9497881
5.

Testosterone supplementation: what and how to give.

Jockenhövel F.

Aging Male. 2003 Sep;6(3):200-6.

PMID:
14628500
6.

Testosterone therapy--what, when and to whom?

Jockenhövel F.

Aging Male. 2004 Dec;7(4):319-24. Review.

PMID:
15799128
7.

New long-acting androgens.

Gooren LJ.

World J Urol. 2003 Nov;21(5):306-10. Epub 2003 Oct 9. Review.

PMID:
14551719
8.

Testosterone treatment comes of age: new options for hypogonadal men.

Nieschlag E.

Clin Endocrinol (Oxf). 2006 Sep;65(3):275-81. Review.

PMID:
16918944
9.

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.

Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, Sanders SW, Odell WD.

J Clin Endocrinol Metab. 1992 Mar;74(3):623-8.

PMID:
1740497
10.

Testosterone replacement therapy.

Velázquez E, Bellabarba Arata G.

Arch Androl. 1998 Sep-Oct;41(2):79-90. Review.

PMID:
9730436
11.

[Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].

Asscheman H, Gooren LJ.

Ned Tijdschr Geneeskd. 2000 Apr 29;144(18):847-50. Dutch.

PMID:
10816775
12.

Which testosterone replacement therapy?

Cantrill JA, Dewis P, Large DM, Newman M, Anderson DC.

Clin Endocrinol (Oxf). 1984 Aug;21(2):97-107.

PMID:
6467640
13.

Male hypogonadism : an update on diagnosis and treatment.

Darby E, Anawalt BD.

Treat Endocrinol. 2005;4(5):293-309. Review.

PMID:
16185098
14.

Experience with transdermal testosterone replacement therapy for hypogonadal men.

Parker S, Armitage M.

Clin Endocrinol (Oxf). 1999 Jan;50(1):57-62.

PMID:
10341856
15.

Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men.

Jockenhövel F, Bullmann C, Schubert M, Vogel E, Reinhardt W, Reinwein D, Müller-Wieland D, Krone W.

Metabolism. 1999 May;48(5):590-6.

PMID:
10337859
16.

Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.

Behre HM, von Eckardstein S, Kliesch S, Nieschlag E.

Clin Endocrinol (Oxf). 1999 May;50(5):629-35.

PMID:
10468929
17.

Androgen levels and sex functions in testosterone-treated hypogonadal men.

Gooren LJ.

Arch Sex Behav. 1987 Dec;16(6):463-73.

PMID:
3426390
18.

Testosterone depot injection in male hypogonadism: a critical appraisal.

Yassin AA, Haffejee M.

Clin Interv Aging. 2007;2(4):577-90. Review.

19.

Testosterone deficiency and replacement.

Howell S, Shalet S.

Horm Res. 2001;56 Suppl 1:86-92. Review.

PMID:
11786693
20.

Testosterone undecanoate in the treatment of male hypogonadism.

Edelstein D, Basaria S.

Expert Opin Pharmacother. 2010 Aug;11(12):2095-106. doi: 10.1517/14656566.2010.505920. Review.

PMID:
20642374

Supplemental Content

Support Center